443 related articles for article (PubMed ID: 17203844)
1. [Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature].
Neĭman KP; Rumiantsev VG
Eksp Klin Gastroenterol; 2006; (3):56-60. PubMed ID: 17203844
[No Abstract] [Full Text] [Related]
2. [Therapy of chronic inflammatory bowel diseases].
Beglinger C
Ther Umsch; 1997 Nov; 54(11):649-53. PubMed ID: 9454368
[TBL] [Abstract][Full Text] [Related]
3. Controversies with aminosalicylates in inflammatory bowel disease.
Lim WC; Hanauer SB
Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
[TBL] [Abstract][Full Text] [Related]
4. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
Moum B
Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2565-7. PubMed ID: 14714043
[TBL] [Abstract][Full Text] [Related]
5. Drug insight: aminosalicylates for the treatment of IBD.
Nielsen OH; Munck LK
Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of colitis ulcerosa and Crohn's disease].
Kovács A
Orv Hetil; 2006 Apr; 147(16):755-8. PubMed ID: 16711262
[No Abstract] [Full Text] [Related]
7. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease.
Feagan BG
Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385
[No Abstract] [Full Text] [Related]
8. Mesalamine derivatives in the treatment of Crohn's disease.
Harrell LE; Hanauer SB
Gastroenterol Clin North Am; 2004 Jun; 33(2):303-17, ix-x. PubMed ID: 15177540
[TBL] [Abstract][Full Text] [Related]
9. [Inflammatory bowel diseases].
Kruis W
Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S73-5. PubMed ID: 15368174
[No Abstract] [Full Text] [Related]
10. Maintenance strategies in Crohn's disease.
Sachar DB
Hosp Pract (1995); 1996 Jan; 31(1):99-106. PubMed ID: 8595995
[TBL] [Abstract][Full Text] [Related]
11. [Crohn disease and ulcerative colitis - current status: internal medicine aspects].
Ewe K; Karbach U
Chirurg; 1981 Dec; 52(12):744-8. PubMed ID: 6119189
[No Abstract] [Full Text] [Related]
12. [Colorectal cancer in inflammatory bowel disease].
Henriksen M; Moum B
Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155
[TBL] [Abstract][Full Text] [Related]
13. Education and imaging. Gastrointestinal: gastric Crohn's disease.
Tseng TC; Chang YT; Wong JM
J Gastroenterol Hepatol; 2007 Oct; 22(10):1690. PubMed ID: 17845696
[No Abstract] [Full Text] [Related]
14. [Inflammatory diseases of the intestines].
Felley C; Guyot J; Hess J; Mottet C; Delarive J; Michetti P
Rev Med Suisse; 2006 Jan; 2(49):191-4, 196-8, 201-3. PubMed ID: 16493962
[TBL] [Abstract][Full Text] [Related]
15. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
MMW Fortschr Med; 2009 May; 151(19):38-9. PubMed ID: 19827443
[No Abstract] [Full Text] [Related]
16. [Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
Feurle GE; Helmstädter V
Dtsch Med Wochenschr; 1986 May; 111(18):721-2. PubMed ID: 2870908
[No Abstract] [Full Text] [Related]
17. [Association between membranous glomerulonephritis and Crohn's disease].
Díaz Rodríguez C; Granja E; Vázquez Martul E; Sacristán F; Moreno Fernández A; González Rivero C; del Río Romero D; Trinidad JC
Nefrologia; 2004; 24(4):368-71. PubMed ID: 15455498
[TBL] [Abstract][Full Text] [Related]
18. [Ulcerative and granulomatous colitis].
Bosseckert H
Z Gesamte Inn Med; 1981 Jan; 36(1):suppl 207-8. PubMed ID: 6111867
[TBL] [Abstract][Full Text] [Related]
19. Clinical aspects of ulcerative colitis in mainland China.
Zheng JJ
Chin J Dig Dis; 2006; 7(2):71-5. PubMed ID: 16643333
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacological bases of therapy with 5-ASA].
Beltrán B; Martínez-Cuesta MA; Calatayud S; Hinojosa J; Esplugues JV
Gastroenterol Hepatol; 1997; 20(6):322-34. PubMed ID: 9296850
[No Abstract] [Full Text] [Related]
[Next] [New Search]
